ILUMYA J Code: J3245
Injection, tildrakizumab, 1 mg
Drug & Product Overview
About ILUMYA
Ilumya is a medication aligned to the HCPCS J Code: J3245 for billing, pricing, and reimbursement purposes in the United States. Classified under Immunology: Anti-TNF, it is administered via the subcutaneous route and manufactured by Sun Pharma.
According to CMS Drug Use Information: This medication is used to treat moderate to severe plaque psoriasis. Tildrakizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may lead to the overgrowth of skin cells and redness/swelling seen in plaque psoriasis. Tildrakizumab can help lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 47335-0177-95 | Ilumya | Sun Pharmaceutical Industries, Inc. | 100 | 100 MG / 1 ML |
ILUMYA Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →ILUMYA CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
CMS has identified Ilumya (J3245) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →
ILUMYA Medically Unlikely Edits (MUE)
The most billing units of J3245 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
ILUMYA Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Try Pro free for 7 daysUpgrade to ProAdd Analytics and full history with ProComparative Report
Compare ILUMYA with alternatives
- ILUMYA J3245
- Skyrizi J2327
- TREMFYA J1628
- Omvoh J2267
ASP, the Medicare payment limit, WAC and AWP for all 4 drugs on one timeline, with 10+ years of monthly history.
Card required · cancel anytime
Frequently Asked Questions
Is there an available Ilumya billing and coding guide?
Are there any available Ilumya patient assistance programs?
Where can I find Ilumya prescribing information?
Where can I find Ilumya side effect information?
Does billing ILUMYA require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to ILUMYA.